We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$4.25B
1-Year Est. Return
141.71%
This Fund
S&P 500
This Quarter
Est. Return
+8.58%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$2.77B
AUM Growth
-$242M
(-8%)
Cap. Flow
-$349M
Cap. Flow
% of AUM
-12.6%
Top 10 Holdings %
Top 10 Hldgs %
18.23%
Holding
319
New
33
Increased
50
Reduced
134
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$30.5M |
| 2 |
AdaptHealth
AHCO
|
+$26.6M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$19.6M |
| 4 |
BJ's Restaurants
BJRI
|
+$17.7M |
| 5 |
SI
Silvergate Capital Corporation
SI
|
+$16.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTV
Momentive Global Inc. Common Stock
MNTV
|
+$35.4M |
| 2 |
New Fortress Energy
NFE
|
+$28.3M |
| 3 |
Immunovant
IMVT
|
+$27.9M |
| 4 |
Karyopharm Therapeutics
KPTI
|
+$25M |
| 5 |
TMHC
Taylor Morrison
TMHC
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.33% |
| 2 | Technology | 20.26% |
| 3 | Consumer Discretionary | 16.91% |
| 4 | Industrials | 14.7% |
| 5 | Financials | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Freshpet
FRPT
$3.35B
| $63.5M | 2.29% |
399,538
-94,395
| -19% | -$14.2M |
|
2
NeoGenomics
NEO
$2.24B
| $57M | 2.06% |
1,182,382
-168,423
| -12% | -$8.77M |
|
3
Churchill Downs
CHDN
$6.29B
| $53.2M | 1.92% |
467,942
-56,596
| -11% | -$6.23M |
|
4
Chegg
CHGG
$109M
| $50.3M | 1.81% |
587,017
-229,631
| -28% | -$21.9M |
|
5
Varonis Systems
VRNS
$5.34B
| $49.7M | 1.8% |
968,956
-140,450
| -13% | -$8.33M |
|
|
GTLS
6
DELISTED
Chart Industries
GTLS
| $49.1M | 1.77% |
344,743
-60,432
| -15% | -$8.53M |
|
7
MACOM Technology Solutions
MTSI
$19.9B
| $48.7M | 1.76% |
839,944
-110,541
| -12% | -$6.85M |
|
8
Rapid7
RPD
$773M
| $46.1M | 1.66% |
618,077
-76,258
| -11% | -$6.34M |
|
|
PPBI
9
DELISTED
Pacific Premier Bancorp
PPBI
| $44.2M | 1.6% |
1,018,087
-89,820
| -8% | -$3.5M |
|
10
Tetra Tech
TTEK
$9.29B
| $43.3M | 1.56% |
1,594,995
-215,600
| -12% | -$5.71M |
|
11
Moelis & Co
MC
$5.12B
| $42.7M | 1.54% |
778,497
-49,139
| -6% | -$2.63M |
|
12
Eastern Bankshares
EBC
$5.05B
| $40.5M | 1.46% |
2,101,961
+348,505
| +20% | +$6.06M |
|
13
Jack in the Box
JACK
$291M
| $40.4M | 1.46% |
368,145
-41,970
| -10% | -$4.27M |
|
14
Kratos Defense & Security Solutions
KTOS
$9.03B
| $40.3M | 1.45% |
1,476,885
-391,634
| -21% | -$11M |
|
15
Trex
TREX
$4.45B
| $37.4M | 1.35% |
408,940
-121,766
| -23% | -$11.5M |
|
16
Avient
AVNT
$3.94B
| $36.2M | 1.31% |
766,790
-25,940
| -3% | -$1.16M |
|
17
Simply Good Foods
SMPL
$1.02B
| $34.4M | 1.24% |
1,132,250
-420,718
| -27% | -$12.5M |
|
|
BWIN
18
Baldwin Insurance Group
BWIN
$3.02B
| $33.9M | 1.22% |
1,243,751
-155,982
| -11% | -$4.24M |
|
19
AtriCure
ATRC
$2.67B
| $32.8M | 1.19% |
501,311
-34,788
| -6% | -$2.14M |
|
20
United Therapeutics
UTHR
$21B
| $32.5M | 1.17% |
194,528
-18,426
| -9% | -$3.07M |
|
21
Onto Innovation
ONTO
$15.4B
| $32M | 1.16% |
487,526
-22,356
| -4% | -$1.33M |
|
|
SAIL
22
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $32M | 1.16% |
632,471
-75,000
| -11% | -$4.22M |
|
23
TriNet
TNET
$3.19B
| $30.8M | 1.11% |
395,030
-43,930
| -10% | -$3.55M |
|
24
BellRing Brands
BRBR
$1.21B
| $29.3M | 1.06% |
1,239,243
-130,952
| -10% | -$3.19M |
|
25
Five Below
FIVE
$13.3B
| $29.2M | 1.05% |
153,145
-19,291
| -11% | -$3.64M |
|
Similar funds
AP
QWP
HMC
SCA
MA
TFM
IAA
CAM
Emerald Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Emerald Advisers held 319 positions worth $2.77B, down 8% from $3.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Advisers withdrew a net $349M in Q1 2021, closing 77 positions and reducing 134 holdings. Its most notable exit was Momentive Global Inc. Common Stock, an estimated $35.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Emerald Advisers opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $26.1M.
- Emerald Advisers's largest Q1 2021 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 261,467 shares worth $26.1M.
- Emerald Advisers added most to AdaptHealth in Q1 2021, an estimated $26.6M increase.
- Emerald Advisers's biggest Q1 2021 reduction was New Fortress Energy, cutting an estimated $28.3M.
- Emerald Advisers fully exited Momentive Global Inc. Common Stock in Q1 2021, selling an estimated $35.4M.
- Emerald Advisers's ten largest holdings make up 18% of its $2.77B portfolio in Q1 2021.
- Emerald Advisers opened 33 new positions and closed 77 in Q1 2021.
- Emerald Advisers's portfolio value fell 8% quarter-over-quarter to $2.77B.
Based on Emerald Advisers's 13F filing for Q1 2021, filed 29 Apr 2021.